论文部分内容阅读
目的该文就干扰素联合炎琥宁治疗小儿手足口病的临床效果进行研究。方法选取该院儿科在2014年10月—2015年10月期间收治的40例小儿手足口病患者,按照随机数字表法分为实验组与参照组,各20例。对实验组患儿采用干扰素联合炎琥宁治疗,对参照组患儿单纯采用炎琥宁治疗,对比两组患儿的治疗总有效率、康复时间及不良反应。结果实验组患儿的治疗总有效率显著高于参照组,退热时间、手足皮疹消退时间、口腔溃疡消退时间对比参照组更快更短(P<0.05);两组患儿的不良反应发生率比较差异无统计学意义(P>0.05)。结论应用干扰素联合炎琥宁治疗小儿手足口病安全又有效,对加快患儿康复速度也有显著帮助,值得推广。
Objective To study the clinical effect of interferon combined with mesylate in the treatment of hand-foot-mouth disease in children. Methods Forty pediatric HFMD patients admitted to our hospital from October 2014 to October 2015 were selected and randomly divided into experimental group and reference group according to the random number table. The experimental group of children with interferon combined with the treatment of meningitis, the reference group of children treated with melatonin alone, the two groups were compared the total effective rate of treatment, recovery time and adverse reactions. Results The total effective rate of treatment group was significantly higher than that of the reference group, and the antipyretic time, hand-foot rash subsidence time and oral ulcer subsidence time were faster and shorter than those of the reference group (P <0.05). Adverse reactions occurred in both groups The difference was not statistically significant (P> 0.05). Conclusion The application of interferon combined with midazolam is safe and effective in the treatment of hand-foot-mouth disease in children. It is also helpful to speed up the rehabilitation of children and is worth promoting.